Lysyl oxidase

Error creating thumbnail:

PTMofLysine.svg

Lysyl oxidase (LOX) is an enzyme that plays a crucial role in the biosynthesis of collagen and elastin. It is a copper-dependent amine oxidase that catalyzes the cross-linking of collagen and elastin in the extracellular matrix, which is essential for the structural integrity and function of various tissues.

Function

Lysyl oxidase initiates the formation of covalent cross-links in collagen and elastin by oxidizing the ε-amino group of lysine residues to form reactive aldehydes. These aldehydes then undergo spontaneous chemical reactions to form cross-links, which stabilize the extracellular matrix and contribute to the mechanical properties of tissues such as skin, bone, and blood vessels.

Structure

The enzyme is synthesized as a precursor molecule, known as pro-lysyl oxidase, which undergoes proteolytic processing to become the active enzyme. The active form of lysyl oxidase contains a copper ion at its active site, which is essential for its catalytic activity. The enzyme also contains a lysine tyrosylquinone (LTQ) cofactor, which is formed by the post-translational modification of a lysine and a tyrosine residue.

Genetics

The gene encoding lysyl oxidase is located on chromosome 5 in humans. Mutations in the LOX gene can lead to various connective tissue disorders due to the impaired cross-linking of collagen and elastin.

Clinical Significance

Lysyl oxidase is implicated in several pathological conditions. Overexpression of LOX has been associated with fibrosis, where excessive cross-linking of collagen leads to tissue stiffening and scarring. Conversely, reduced LOX activity is linked to conditions such as Menkes disease, a disorder of copper metabolism that results in defective collagen and elastin cross-linking.

Research and Therapeutic Potential

Given its role in tissue remodeling and repair, lysyl oxidase is a target of interest in the development of therapies for fibrotic diseases, cancer, and other conditions involving extracellular matrix abnormalities. Inhibitors of LOX are being explored as potential treatments for fibrosis and cancer metastasis.

See Also

• Collagen
• Elastin
• Extracellular matrix
• Fibrosis
• Menkes disease